Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Deuterated etifoxine by GABA Therapeutics for Neuropathic Pain (Neuralgia): Likelihood of Approval
Deuterated etifoxine is under clinical development by GABA Therapeutics and currently in Phase I for Neuropathic Pain (Neuralgia). According to...
Deuterated etifoxine by GABA Therapeutics for Post Partum Depression (Maternal Depression / Postnatal Depression): Likelihood of Approval
Deuterated etifoxine is under clinical development by GABA Therapeutics and currently in Phase I for Post Partum Depression (Maternal Depression...
Deuterated etifoxine by GABA Therapeutics for Social Anxiety Disorder (SAD/Social Phobia): Likelihood of Approval
Deuterated etifoxine is under clinical development by GABA Therapeutics and currently in Phase I for Social Anxiety Disorder (SAD/Social Phobia)....